# PRDM16

## Overview
PRDM16 is a gene that encodes the PR/SET domain 16 protein, a transcriptional regulator with a pivotal role in adipose tissue differentiation and energy metabolism. The protein is characterized by a PR domain, which is similar to the SET domain found in histone methyltransferases, and multiple C2H2 zinc finger motifs that facilitate DNA binding (Di2021The). Although PRDM16 exhibits weak mono-methyltransferase activity, it primarily functions through protein-protein interactions, forming complexes with other transcription factors to regulate gene expression (Ivanochko2018Direct). PRDM16 is crucial for the development and function of brown and beige adipose tissues, influencing energy homeostasis and metabolic processes (Seale2007Transcriptional; Chi2016The). Beyond adipose tissue, PRDM16 is involved in maintaining stem cell populations in the hematopoietic and nervous systems, highlighting its multifunctional nature (Ishibashi2015Functions). The gene's expression and mutations are linked to various clinical conditions, including cardiomyopathy and hematological malignancies, underscoring its significance in human health (Chi2016The; Casamassimi2020Multifaceted).

## Structure
PRDM16 is a transcription factor characterized by a PR domain, which is similar to the SET domain found in histone methyltransferases, and multiple C2H2 zinc finger motifs that facilitate DNA binding (Di2021The). The PR domain in PRDM16 is noted for its weak mono-methyltransferase activity on lysine 9 of histone H3, although it lacks a key catalytic tyrosine residue found in other enzymatic SET domains, suggesting an alternative function (Ivanochko2018Direct). 

PRDM16 exists in different isoforms due to alternative splicing, with the longer isoform containing the PR domain and the shorter isoform lacking it, acting as a dominant negative in cancer (Di2021The). The full-length isoforms of PRDM16 include an N-terminal unstructured region preceding the PR-SET domain, which is absent in the shorter isoforms (Ivanochko2018Direct). 

The N-terminal residues of PRDM16 interact with the RBBP4 component of the NuRD chromatin remodeling complex, with specific interactions involving residues 1-12. These interactions include salt bridges, hydrogen bonds, hydrophobic contacts, and cation-stacking, which are crucial for binding to RBBP4 (Ivanochko2018Direct). The structural data for PRDM16 bound to RBBP4 is detailed in PDB structures 6bw3 and 6bw4 (Ivanochko2018Direct).

## Function
PRDM16 is a transcriptional regulator that plays a crucial role in the differentiation and function of brown and beige adipose tissues. It primarily operates through protein-protein interactions rather than direct DNA binding, forming complexes with transcription factors such as C/EBPb, PPARγ, and PGC-1α to promote the expression of genes involved in brown fat differentiation and thermogenesis (Seale2007Transcriptional; Chi2016The). PRDM16 enhances mitochondrial gene expression and density, which are key characteristics of brown fat cells, and increases the uncoupled fraction of respiration, contributing to thermogenic activity (Seale2007Transcriptional).

In adipose tissue, PRDM16 is essential for the development of brown fat during embryogenesis and beige fat within white fat depots. It influences energy homeostasis, glucose and lipid metabolism, and body weight regulation (Chi2016The). PRDM16 can induce a brown fat-like program in white fat cells, leading to increased energy expenditure and improved insulin sensitivity (Chi2016The). It also interacts with the histone methyltransferase EHMT1 to suppress the expression of white and muscle-selective genes through epigenetic modifications (Chi2016The).

PRDM16's role extends beyond adipose tissue, as it is involved in maintaining certain stem cell populations in the hematopoietic and nervous systems, where it modulates oxidative stress (Ishibashi2015Functions). Its expression is regulated at multiple levels, including transcriptional, translational, and post-translational, and it is expressed in various tissues, indicating its multifunctional nature (Ishibashi2015Functions; Chi2016The).

## Clinical Significance
Mutations and alterations in the expression of the PRDM16 gene are associated with several diseases and conditions. In cardiomyopathy, PRDM16 mutations can lead to left ventricular noncompaction or dilated cardiomyopathy, particularly in individuals with chromosome 1p36 deletion syndrome, which is linked to severe intellectual disability (Chi2016The; herbst2020characterization). PRDM16 is also frequently mutated in both pediatric and adult cardiomyopathies, suggesting its significant role in these diseases (herbst2020characterization).

In hematological malignancies, PRDM16 is implicated in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) through chromosomal rearrangements and translocations, such as t(1;3)(p36;q21), leading to its overexpression (Hu2019PRDM16s; Casamassimi2020Multifaceted). The short isoform, sPRDM16, is particularly associated with poor prognosis in AML and is linked to TGF-β resistance and inflammatory pathways (Hu2019PRDM16s; Corrigan2018PRDM16).

In solid tumors, PRDM16 exhibits variable roles. It acts as an oncogene in osteosarcoma and gastric cancer, while in lung cancer, it functions as a tumor suppressor, with high expression correlating with better survival (Fei2019PRDM16; Casamassimi2020Multifaceted). PRDM16's methylation status is also significant, with hypomethylation linked to poor prognosis in astrocytoma and glioblastoma (Casamassimi2020Multifaceted).

## Interactions
PRDM16 is a transcriptional regulator that participates in various protein-protein interactions crucial for its role in adipocyte differentiation and energy metabolism. It forms a transcriptional complex with C-terminal-binding proteins (CtBP-1 and CtBP-2), which is essential for repressing white fat-specific genes (Kajimura2008Regulation). PRDM16 also interacts with PPAR-γ-coactivator-1α (PGC-1α) and PGC-1β, which displace CtBP from the complex, thereby activating brown fat-specific genes (Kajimura2008Regulation).

PRDM16 interacts with the NuRD chromatin remodeling complex through its N-terminal residues, specifically binding to the RBBP4 component. This interaction is significant for its role in regulating epigenetic machinery and is mediated by a conserved interaction network resembling the histone H3 peptide (Ivanochko2018Direct). The full-length PRDM16 isoform, which includes an unstructured region preceding the PR-SET domain, is necessary for these interactions, as the truncated isoforms do not engage with the NuRD complex (Ivanochko2018Direct).

PRDM16 also enhances transcription of the brown fat-specific Ucp1 gene through interactions with the mediator subunit MED1, involving its zinc finger domains (Iida2015PRDM16). These interactions highlight PRDM16's role in transcriptional regulation and chromatin remodeling.


## References


[1. (Hu2019PRDM16s) Tianyuan Hu, Kiyomi Morita, Matthew C. Hill, Yajian Jiang, Ayumi Kitano, Yusuke Saito, Feng Wang, Xizeng Mao, Kevin A. Hoegenauer, Kazuhiro Morishita, James F. Martin, P. Andrew Futreal, Koichi Takahashi, and Daisuke Nakada. Prdm16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells. Blood, 134(7):614–625, August 2019. URL: http://dx.doi.org/10.1182/blood.2018888255, doi:10.1182/blood.2018888255. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.2018888255)

[2. (Ishibashi2015Functions) Jeff Ishibashi and Patrick Seale. Functions of prdm16 in thermogenic fat cells. Temperature, 2(1):65–72, March 2015. URL: http://dx.doi.org/10.4161/23328940.2014.974444, doi:10.4161/23328940.2014.974444. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/23328940.2014.974444)

[3. (Kajimura2008Regulation) Shingo Kajimura, Patrick Seale, Takuya Tomaru, Hediye Erdjument-Bromage, Marcus P. Cooper, Jorge L. Ruas, Sherry Chin, Paul Tempst, Mitchell A. Lazar, and Bruce M. Spiegelman. Regulation of the brown and white fat gene programs through a prdm16/ctbp transcriptional complex. Genes &amp; Development, 22(10):1397–1409, May 2008. URL: http://dx.doi.org/10.1101/gad.1666108, doi:10.1101/gad.1666108. This article has 368 citations.](https://doi.org/10.1101/gad.1666108)

4. (herbst2020characterization) Characterization of Genetic Causes of Pediatric Cardiomyopathies--Analysis of PRDM16 as a Major Disease Gene. This article has 0 citations.

[5. (Casamassimi2020Multifaceted) Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, Anna Sorrentino, Donatella Fiore, Maria Chiara Proto, Bruno Moncharmont, Patrizia Gazzerro, Maurizio Bifulco, and Ciro Abbondanza. Multifaceted role of prdm proteins in human cancer. International Journal of Molecular Sciences, 21(7):2648, April 2020. URL: http://dx.doi.org/10.3390/ijms21072648, doi:10.3390/ijms21072648. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21072648)

[6. (Chi2016The) Jingyi Chi and Paul Cohen. The multifaceted roles of prdm16: adipose biology and beyond. Trends in Endocrinology &amp; Metabolism, 27(1):11–23, January 2016. URL: http://dx.doi.org/10.1016/j.tem.2015.11.005, doi:10.1016/j.tem.2015.11.005. This article has 75 citations.](https://doi.org/10.1016/j.tem.2015.11.005)

[7. (Corrigan2018PRDM16) David J. Corrigan, Larry L. Luchsinger, Mariana Justino de Almeida, Linda J. Williams, Alexandros Strikoudis, and Hans-Willem Snoeck. Prdm16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature. Journal of Clinical Investigation, 128(8):3250–3264, July 2018. URL: http://dx.doi.org/10.1172/jci99862, doi:10.1172/jci99862. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci99862)

[8. (Iida2015PRDM16) Satoshi Iida, Wei Chen, Tomoyoshi Nakadai, Yoshiaki Ohkuma, and Robert G. Roeder. Prdm16 enhances nuclear receptor-dependent transcription of the brown fat-specific ucp1 gene through interactions with mediator subunit med1. Genes &amp; Development, 29(3):308–321, February 2015. URL: http://dx.doi.org/10.1101/gad.252809.114, doi:10.1101/gad.252809.114. This article has 82 citations.](https://doi.org/10.1101/gad.252809.114)

[9. (Seale2007Transcriptional) Patrick Seale, Shingo Kajimura, Wenli Yang, Sherry Chin, Lindsay M. Rohas, Marc Uldry, Geneviève Tavernier, Dominique Langin, and Bruce M. Spiegelman. Transcriptional control of brown fat determination by prdm16. Cell Metabolism, 6(1):38–54, July 2007. URL: http://dx.doi.org/10.1016/j.cmet.2007.06.001, doi:10.1016/j.cmet.2007.06.001. This article has 1328 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cmet.2007.06.001)

[10. (Fei2019PRDM16) Liang-Ru Fei, Wen-Jing Huang, Yuan Wang, Lei Lei, Zhi-Han Li, Yi-Wen Zheng, Zhao Wang, Mai-Qing Yang, Chen-Chen Liu, and Hong-Tao Xu. Prdm16 functions as a suppressor of lung adenocarcinoma metastasis. Journal of Experimental &amp; Clinical Cancer Research, January 2019. URL: http://dx.doi.org/10.1186/s13046-019-1042-1, doi:10.1186/s13046-019-1042-1. This article has 30 citations.](https://doi.org/10.1186/s13046-019-1042-1)

[11. (Di2021The) Federico Di Tullio, Megan Schwarz, Habiba Zorgati, Slim Mzoughi, and Ernesto Guccione. The duality of prdm proteins: epigenetic and structural perspectives. The FEBS Journal, 289(5):1256–1275, May 2021. URL: http://dx.doi.org/10.1111/febs.15844, doi:10.1111/febs.15844. This article has 35 citations.](https://doi.org/10.1111/febs.15844)

[12. (Ivanochko2018Direct) Danton Ivanochko, Levon Halabelian, Elizabeth Henderson, Pavel Savitsky, Harshika Jain, Edyta Marcon, Shili Duan, Ashley Hutchinson, Alma Seitova, Dalia Barsyte-Lovejoy, Panagis Filippakopoulos, Jack Greenblatt, Evelyne Lima-Fernandes, and Cheryl H Arrowsmith. Direct interaction between the prdm3 and prdm16 tumor suppressors and the nurd chromatin remodeling complex. Nucleic Acids Research, 47(3):1225–1238, November 2018. URL: http://dx.doi.org/10.1093/nar/gky1192, doi:10.1093/nar/gky1192. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gky1192)